Significance of MIB-1 Staining Indices in Meningiomas: Comparison of Two Counting Methods

The authors evaluated the predictability of MIB-1 immunohistochemistry for growth and recurrences of meningiomas using two different counting methods: 1) in the area of the highest MIB-1 labeling (HL method) and (2) in randomly selected fields (RS method). The MIB-1 staining indices (SIs) determined by the HL method were approximately twice as high as those by the RS method, and the correlation coefficient between them was high (R = 0.86) in 139 meningiomas when transformed logarithmically. The differences in SIs in histologic grades were significant with either method. Tumor doubling time (Td) was calculated in 22 meningiomas from serial radiologic examinations. The RS method yielded a slightly higher correlation coefficient between log Td and log SI than the HL method. When the authors examined the predictability of recurrence in 112 totally removed meningiomas, the RS method distinguished the recurrent group more definitively. Several benign meningiomas with low SIs by the RS method exhibited focal accumulation of MIB-1-positive cells. Although they were assigned high MIB-1 values by the HL method, these meningiomas did not recur, and therefore obscured the prognostic importance of the MIB-1 value with the HL method. Focal accumulation of MIB-1-positive cells in meningiomas is not likely to correlate with their biologic aggressiveness.

[1]  C. Cornelisse,et al.  Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. , 1989, Cancer research.

[2]  L. Langford,et al.  Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. , 1996, Human pathology.

[3]  大田 正流 MIB1 staining index and scoring of histologic features in meningioma , 1995 .

[4]  A. Probst,et al.  Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. , 1998, Human pathology.

[5]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[6]  J. Gerdes,et al.  Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. , 1992, The Journal of pathology.

[7]  R. Prayson,et al.  MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. , 1998, Human pathology.

[8]  A. Asai,et al.  Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas , 1996, Acta Neuropathologica.

[9]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.

[10]  Charles B. Wilson,et al.  Proliferative potential of brain tumors. Analyses with Ki‐67 and anti‐dna polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts , 1993, Cancer.

[11]  J. Hendricks,et al.  Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  S. Nakasu,et al.  p53 accumulation and apoptosis in embolized meningiomas , 1997, Acta Neuropathologica.

[13]  G. van Melle,et al.  The implications of the heterogeneous distribution of Ki-67 labelled cells in meningiomas. , 1989, British journal of neurosurgery.

[14]  R. Prayson,et al.  Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. , 1999, Archives of pathology & laboratory medicine.

[15]  B. Scheithauer,et al.  The prognostic significance of MIB‐1, p53, and DNA flow cytometry in completely resected primary meningiomas , 1998, Cancer.

[16]  中洲 敏,et al.  計測方法によるMIB-1 staining indexの差 : 髄膜腫における検討 , 1998 .

[17]  C. Madsen,et al.  Ki-67 immunoreactivity in meningiomas--determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67. , 1997, Clinical neuropathology.

[18]  Hsu,et al.  MIB‐1(Ki‐67) index and transforming growth factor‐alpha (TGFα) immunoreactivity are significant prognostic predictors for meningiomas , 1998, Neuropathology and applied neurobiology.

[19]  B. Scheithauer,et al.  "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. , 1999, Cancer.

[20]  M. Khan,et al.  The recurrence of intracranial meningiomas after surgical treatment. , 1983, Journal of neurosurgery.

[21]  森村 達夫 In situ analysis of cell kinetics in human brain tumors , 1990 .

[22]  S. Nakasu,et al.  Preoperative identification of meningiomas that are highly likely to recur. , 1999, Journal of neurosurgery.

[23]  M. Fukui,et al.  MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management , 1994, Cancer.